Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus

BACKGROUND/AIMS: Adefovir dipivoxil (ADV) is a nucleotide analogue that is effective against lamivudine-resistant hepatitis B virus (HBV). The aim of this study was to determine the long-term clinical outcomes after ADV rescue therapy in decompensated patients infected with lamivudine-resistant HBV....

Descripción completa

Detalles Bibliográficos
Autores principales: Woo, Hyun Young, Choi, Jong Young, Yoon, Seung Kew, Suh, Dong Jin, Paik, Seung Woon, Han, Kwang Hyub, Um, Soon Ho, Kim, Byung Ik, Lee, Heon Ju, Cho, Mong, Lee, Chun Kyon, Kim, Dong Joon, Hwang, Jae Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099332/
https://www.ncbi.nlm.nih.gov/pubmed/25032183
http://dx.doi.org/10.3350/cmh.2014.20.2.168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099332/
https://www.ncbi.nlm.nih.gov/pubmed/25032183
http://dx.doi.org/10.3350/cmh.2014.20.2.168

Ejemplares similares